Why is Hunan Fangsheng Pharmaceutical Co., Ltd. ?
1
- OPERATING CASH FLOW(Y) Highest at CNY 303.14 MM
- DEBT-EQUITY RATIO (HY) Lowest at 22.07 %
- RAW MATERIAL COST(Y) Fallen by -4.11% (YoY)
2
With ROE of 17.14%, it has a very attractive valuation with a 3.24 Price to Book Value
- Over the past year, while the stock has generated a return of 25.03%, its profits have risen by 34.3% ; the PEG ratio of the company is 0.6
- At the current price, the company has a high dividend yield of 3.7
How much should you hold?
- Overall Portfolio exposure to Hunan Fangsheng Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Hunan Fangsheng Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hunan Fangsheng Pharmaceutical Co., Ltd.
-4.54%
0.20
33.26%
China Shanghai Composite
21.43%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
5.80%
EBIT Growth (5y)
28.00%
EBIT to Interest (avg)
7.84
Debt to EBITDA (avg)
1.56
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.75
Tax Ratio
11.54%
Dividend Payout Ratio
42.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.65%
ROE (avg)
12.21%
Valuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.37
EV to EBIT
13.19
EV to EBITDA
10.96
EV to Capital Employed
2.25
EV to Sales
2.38
PEG Ratio
0.83
Dividend Yield
6.74%
ROCE (Latest)
17.10%
ROE (Latest)
17.56%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Movement
7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 502.53 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 10.13 %
INTEREST COVERAGE RATIO(Q)
Highest at 4,369.18
RAW MATERIAL COST(Y)
Fallen by -11.76% (YoY
-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.4 times
Here's what is working for Hunan Fangsheng Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Highest at 4,369.18
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio
Lowest at 10.13 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at CNY 502.53 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -11.76% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hunan Fangsheng Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Lowest at 1.4 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






